Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation

被引:209
作者
Lüth, HJ
Münch, G
Arendt, T
机构
[1] Univ Leipzig, Dept Neuroanat, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany
[2] Interdisciplinary Ctr Clin Res, Dept Neuroimmunol Cell Biol, D-04103 Leipzig, Germany
关键词
Alzheimer's disease; nitric oxide synthase; nitrotyrosine;
D O I
10.1016/S0006-8993(02)03280-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Various isoforms of the nitric oxide (NO) producing enzyme nitric oxide synthase (NOS) are elevated in Alzheimer's disease (AD) indicating a critical role for NO in the pathomechanism. NO can react with superoxide to generate peroxynitrite, a process referred to as oxidative stress, which is likely to play a role in AD. Peroxynitrite in turn, nitrates tyrosine residues to form nitrotyrosine which can be identified immunohistochemically. To study the potential structural link between the increased synthesis of NO and the deposition of nitrotyrosine in AD, we analyzed the expression of neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS) in AD and control brain, and compared the localization with the distribution of nitrotyrosine. Nitrotyrosine was detected in neurons, astrocytes and blood vessels in AD cases. Aberrant expression of nNOS in cortical pyramidal cells was highly co-localized with nitrotyrosine. Furthermore, iNOS and eNOS were highly expressed in astrocytes in AD. In addition, double immunolabeling studies revealed that in these glial cells iNOS and eNOS are co-localized with nitrotyrosine. Therefore, it is suggested that increased expression of all NOS isoforms in astrocytes and neurons contributes to the synthesis of peroxynitrite which leads to generation of nitrotyrosine. In view of the wide range of isoform-specific NOS inhibitors, the determination of the most responsible isoform of NOS for the formation of peroxynitrite in AD could be of therapeutic importance in the treatment of Alzheimer's disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 80 条
[51]   Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a [J].
Lüth, HJ ;
Holzer, M ;
Gertz, HJ ;
Arendt, T .
BRAIN RESEARCH, 2000, 852 (01) :45-55
[52]  
MCKHANN G, 1984, NEUROLOGY, V34, P934
[53]   Release of nitric oxide from astroglial cells: A key mechanism in neuroimmune disorders [J].
Mollace, V ;
Nistico, G .
ADVANCES IN NEUROIMMUNOLOGY, 1995, 5 (04) :421-430
[54]   Nitric oxide: discovery and impact on clinical medicine [J].
Moncada, S .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1999, 92 (04) :164-169
[55]   BRAIN GLUTAMATE-DECARBOXYLASE IN PARKINSONS-DISEASE WITH PARTICULAR REFERENCE TO A PREMORTEM SEVERITY INDEX [J].
MONFORT, JC ;
JAVOYAGID, F ;
HAUW, JJ ;
DUBOIS, B ;
AGID, Y .
BRAIN, 1985, 108 (JUN) :301-313
[56]  
Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO
[57]  
2-N
[58]   Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains [J].
Norris, PJ ;
Faull, RLM ;
Emson, PC .
MOLECULAR BRAIN RESEARCH, 1996, 41 (1-2) :36-49
[59]   DURATION OF EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IN GLIAL-CELLS [J].
PARK, SK ;
MURPHY, S .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 39 (04) :405-411
[60]   CYTOKINES IN ALZHEIMERS-DISEASE AND MULTIPLE-SCLEROSIS [J].
PATTERSON, PH .
CURRENT OPINION IN NEUROBIOLOGY, 1995, 5 (05) :642-646